These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MicroRNA-939 Directly Targets Situ J; Zhang H; Jin Z; Li K; Mao Y; Huang W Onco Targets Ther; 2020; 13():4257-4270. PubMed ID: 32547060 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-936 Targets FGF2 to Inhibit Epithelial Ovarian Cancer Aggressiveness by Deactivating the PI3K/Akt Pathway [Retraction]. Onco Targets Ther; 2021; 14():4961-4962. PubMed ID: 34675537 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-188-5p Promotes Epithelial-Mesenchymal Transition by Targeting ID4 Through Wnt/β-Catenin Signaling in Retinoblastoma [Retraction]. Onco Targets Ther; 2023; 16():841-842. PubMed ID: 37881683 [TBL] [Abstract][Full Text] [Related]
5. circPDSS1 Stimulates the Development of Colorectal Cancer via Activating the Wnt/β-Catenin Signaling [Retraction]. Onco Targets Ther; 2021; 14():4635-4636. PubMed ID: 34511930 [TBL] [Abstract][Full Text] [Related]
6. Lupeol Inhibits Growth and Migration in Two Human Colorectal Cancer Cell Lines by Suppression of Wnt-β-Catenin Pathway [Retraction]. Onco Targets Ther; 2020; 13():8371. PubMed ID: 32904005 [TBL] [Abstract][Full Text] [Related]
7. The Silencing of LncRNA-H19 Decreases Chemoresistance of Human Glioma Cells to Temozolomide by Suppressing Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Pathway [Retraction]. Onco Targets Ther; 2022; 15():329-330. PubMed ID: 35418757 [TBL] [Abstract][Full Text] [Related]
8. Dihydrotanshinone I Inhibits the Growth of Osteosarcoma Through the Wnt/β-Catenin Signaling Pathway [Retraction]. Onco Targets Ther; 2023; 16():275-276. PubMed ID: 37078010 [TBL] [Abstract][Full Text] [Related]
9. Upregulated RACK1 Attenuates Gastric Cancer Cell Growth and Epithelial-Mesenchymal Transition via Suppressing Wnt/β-Catenin Signaling [Retraction]. Onco Targets Ther; 2022; 15():585-586. PubMed ID: 35620566 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-665 Inhibits the Oncogenicity of Retinoblastoma by Directly Targeting High-Mobility Group Box 1 and Inactivating the Wnt/β-Catenin Pathway [Retraction]. Cancer Manag Res; 2021; 13():7245-7246. PubMed ID: 34566431 [TBL] [Abstract][Full Text] [Related]
11. LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway [Retraction]. Onco Targets Ther; 2023; 16():281-282. PubMed ID: 37113686 [TBL] [Abstract][Full Text] [Related]
12. Coronin 3 Promotes the Development of Oncogenic Properties in Glioma Through the Wnt/β-Catenin Signaling Pathway [Retraction]. Onco Targets Ther; 2024; 17():145-146. PubMed ID: 38414760 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of MMSET Impairs Breast Cancer Proliferation and Metastasis Through Inhibiting Wnt/β-Catenin Signaling [Retraction]. Onco Targets Ther; 2024; 17():507-508. PubMed ID: 38919548 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-618 Directly Targets Metadherin mRNA to Suppress the Malignant Phenotype of Osteosarcoma Cells by Reducing PTEN-AKT Pathway Output [Retraction]. Onco Targets Ther; 2021; 14():4963-4964. PubMed ID: 34629879 [TBL] [Abstract][Full Text] [Related]
16. microRNA-605 Directly Targets SOX9 to Alleviate the Aggressive Phenotypes of Glioblastoma Multiforme Cell Lines by Deactivating the PI3K/Akt Pathway [Retraction]. Onco Targets Ther; 2021; 14():4739-4740. PubMed ID: 34526778 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-143-3p Suppresses Tumorigenesis by Targeting Catenin-δ1 in Colorectal Cancer [Retraction]. Onco Targets Ther; 2023; 16():233-234. PubMed ID: 37051318 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-675 Directly Targets MAPK1 to Suppress the Oncogenicity of Papillary Thyroid Cancer and is Sponged by Long Non-Coding RNA RMRP [Retraction]. Onco Targets Ther; 2021; 14():4995-4996. PubMed ID: 34675540 [TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA ASB16-AS1 Functions as a miR-760 Sponge to Facilitate the Malignant Phenotype of Osteosarcoma by Increasing HDGF Expression [Retraction]. Onco Targets Ther; 2021; 14():4743-4744. PubMed ID: 34526780 [TBL] [Abstract][Full Text] [Related]
20. Retraction: RORα Suppresses Epithelial-to-Mesenchymal Transition and Invasion in Human Gastric Cancer Cells via the Wnt/β-Catenin Pathway. Frontiers Editorial Office Front Oncol; 2020; 10():607586. PubMed ID: 33194774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]